@lungoncdoc : “Approximately half of the patients who experience disease progression s/p definitive CCRT & IO per PACIFIC regimen have low-volume relapse or oligometastatic relapse & therefore are candidates for further potentially curative-intent ablative therapy.” @IASLC @OncoAlert #lcsm • TwiCopy

Eric K. Singhi, MD

@lungoncdoc

+ Follow

Thoracic Medical Oncologist, Assistant Professor @MDAndersonNews | Patient education & young-onset lung cancer | 🫁#cancer #lcsm @LungCancerRx | Views my own

ID: 1044788031646040064

linkhttps://faculty.mdanderson.org/profiles/eric_singhi.html calendar_today26-09-2018 03:17:32

6,6K Tweet

5,5K Takipçi

1,1K Takip Edilen

Eric K. Singhi, MD

@lungoncdoc

a year ago

“Approximately half of the patients who experience disease progression s/p definitive CCRT & IO per PACIFIC regimen have low-volume relapse or oligometastatic relapse & therefore are candidates for further potentially curative-intent ablative therapy.” IASLC OncoAlert #lcsm

thumb_up_off_alt13

chat_bubble_outline0

repeat4

shareShare